tirzepatide weight loss clinical trial results once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo- controlled, phase 3 Mazdutide vs tirzepatide: comparing dual-agonist

The answer depends on individual health goals, response to therapy, and ongoing medical guidance

Acknowledgements This work was supported by the Research Fund of Ghent University, Belgium, grant BOF08/GOA/004 and BOF14/GOA/010 and Fonds Wetenschappelijk Onderzoek Vlaanderen (grant FWO14/PDO/067)

This simple and cheap injection may be your first step to a better nights sleep

A gradual taper over 48 weeks, paired with lifestyle reinforcement, produces far better long-term outcomes and prevents the psychological shock of sudden appetite surge

& Rampe, D

They're very effective in weight loss." Patients do report side effects like bloating and constipation